世界の心房細動（AF）治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Atrial Fibrillation Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z0498
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、99ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、心房細動（AF）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬品、非手術的処置、手術的処置）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・心房細動（AF）治療の市場動向
・企業の競争状況、市場シェア
・心房細動（AF）治療の種類別市場規模（薬品、非手術的処置、手術的処置）
・心房細動（AF）治療の用途別市場規模（病院、クリニック、外来手術センター）
・心房細動（AF）治療の北米市場規模2016-2027（アメリカ、カナダ）
・心房細動（AF）治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・心房細動（AF）治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・心房細動（AF）治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・心房細動（AF）治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Johnson & Johnson、Abbott、Medtronic、Boston Scientific、Siemens、Biotronik、Koninklijke Philips、AtriCure、CardioFocus、MicroPort Scientific、Sichuan Jinjiang Electronic Science and Technology）
・結論

Atrial fibrillation is an abnormal heart rhythm characterized by rapid and irregular beating of the atria. Often it starts as brief periods of abnormal beating which become longer and possibly constant over time. Often episodes have no symptoms. Occasionally there may be heart palpitations, fainting, lightheadedness, shortness of breath, or chest pain. The disease is associated with an increased risk of heart failure, dementia, and stroke. It is a type of supraventricular tachycardia.
Geographically, the Americas is anticipated to dominate the global atrial fibrillation market owing to a the rise in the adoption of innovative technologies and procedures for the treatment of atrial fibrillation, and advanced healthcare facilities and infrastructure.

Market Analysis and Insights: Global Atrial Fibrillation Treatment Market
The global Atrial Fibrillation Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Atrial Fibrillation Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Atrial Fibrillation Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Atrial Fibrillation Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Atrial Fibrillation Treatment market.

Global Atrial Fibrillation Treatment Scope and Market Size
Atrial Fibrillation Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Atrial Fibrillation Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medications
Non-Surgical Procedures
Surgical Procedures

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Johnson & Johnson
Abbott
Medtronic
Boston Scientific
Siemens
Biotronik
Koninklijke Philips
AtriCure
CardioFocus

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Atrial Fibrillation Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medications
1.2.3 Non-Surgical Procedures
1.2.4 Surgical Procedures
1.3 Market by Application
1.3.1 Global Atrial Fibrillation Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Atrial Fibrillation Treatment Market Perspective (2016-2027)
2.2 Atrial Fibrillation Treatment Growth Trends by Regions
2.2.1 Atrial Fibrillation Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Atrial Fibrillation Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Atrial Fibrillation Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Atrial Fibrillation Treatment Industry Dynamic
2.3.1 Atrial Fibrillation Treatment Market Trends
2.3.2 Atrial Fibrillation Treatment Market Drivers
2.3.3 Atrial Fibrillation Treatment Market Challenges
2.3.4 Atrial Fibrillation Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Atrial Fibrillation Treatment Players by Revenue
3.1.1 Global Top Atrial Fibrillation Treatment Players by Revenue (2016-2021)
3.1.2 Global Atrial Fibrillation Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Atrial Fibrillation Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Atrial Fibrillation Treatment Revenue
3.4 Global Atrial Fibrillation Treatment Market Concentration Ratio
3.4.1 Global Atrial Fibrillation Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Atrial Fibrillation Treatment Revenue in 2020
3.5 Atrial Fibrillation Treatment Key Players Head office and Area Served
3.6 Key Players Atrial Fibrillation Treatment Product Solution and Service
3.7 Date of Enter into Atrial Fibrillation Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Atrial Fibrillation Treatment Breakdown Data by Type
4.1 Global Atrial Fibrillation Treatment Historic Market Size by Type (2016-2021)
4.2 Global Atrial Fibrillation Treatment Forecasted Market Size by Type (2022-2027)

5 Atrial Fibrillation Treatment Breakdown Data by Application
5.1 Global Atrial Fibrillation Treatment Historic Market Size by Application (2016-2021)
5.2 Global Atrial Fibrillation Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Atrial Fibrillation Treatment Market Size (2016-2027)
6.2 North America Atrial Fibrillation Treatment Market Size by Type
6.2.1 North America Atrial Fibrillation Treatment Market Size by Type (2016-2021)
6.2.2 North America Atrial Fibrillation Treatment Market Size by Type (2022-2027)
6.2.3 North America Atrial Fibrillation Treatment Market Size by Type (2016-2027)
6.3 North America Atrial Fibrillation Treatment Market Size by Application
6.3.1 North America Atrial Fibrillation Treatment Market Size by Application (2016-2021)
6.3.2 North America Atrial Fibrillation Treatment Market Size by Application (2022-2027)
6.3.3 North America Atrial Fibrillation Treatment Market Size by Application (2016-2027)
6.4 North America Atrial Fibrillation Treatment Market Size by Country
6.4.1 North America Atrial Fibrillation Treatment Market Size by Country (2016-2021)
6.4.2 North America Atrial Fibrillation Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Atrial Fibrillation Treatment Market Size (2016-2027)
7.2 Europe Atrial Fibrillation Treatment Market Size by Type
7.2.1 Europe Atrial Fibrillation Treatment Market Size by Type (2016-2021)
7.2.2 Europe Atrial Fibrillation Treatment Market Size by Type (2022-2027)
7.2.3 Europe Atrial Fibrillation Treatment Market Size by Type (2016-2027)
7.3 Europe Atrial Fibrillation Treatment Market Size by Application
7.3.1 Europe Atrial Fibrillation Treatment Market Size by Application (2016-2021)
7.3.2 Europe Atrial Fibrillation Treatment Market Size by Application (2022-2027)
7.3.3 Europe Atrial Fibrillation Treatment Market Size by Application (2016-2027)
7.4 Europe Atrial Fibrillation Treatment Market Size by Country
7.4.1 Europe Atrial Fibrillation Treatment Market Size by Country (2016-2021)
7.4.2 Europe Atrial Fibrillation Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Atrial Fibrillation Treatment Market Size (2016-2027)
8.2 Asia-Pacific Atrial Fibrillation Treatment Market Size by Type
8.2.1 Asia-Pacific Atrial Fibrillation Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Atrial Fibrillation Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Atrial Fibrillation Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Atrial Fibrillation Treatment Market Size by Application
8.3.1 Asia-Pacific Atrial Fibrillation Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Atrial Fibrillation Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Atrial Fibrillation Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Atrial Fibrillation Treatment Market Size by Region
8.4.1 Asia-Pacific Atrial Fibrillation Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Atrial Fibrillation Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Atrial Fibrillation Treatment Market Size (2016-2027)
9.2 Latin America Atrial Fibrillation Treatment Market Size by Type
9.2.1 Latin America Atrial Fibrillation Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Atrial Fibrillation Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Atrial Fibrillation Treatment Market Size by Type (2016-2027)
9.3 Latin America Atrial Fibrillation Treatment Market Size by Application
9.3.1 Latin America Atrial Fibrillation Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Atrial Fibrillation Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Atrial Fibrillation Treatment Market Size by Application (2016-2027)
9.4 Latin America Atrial Fibrillation Treatment Market Size by Country
9.4.1 Latin America Atrial Fibrillation Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Atrial Fibrillation Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Atrial Fibrillation Treatment Market Size (2016-2027)
10.2 Middle East & Africa Atrial Fibrillation Treatment Market Size by Type
10.2.1 Middle East & Africa Atrial Fibrillation Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Atrial Fibrillation Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Atrial Fibrillation Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Atrial Fibrillation Treatment Market Size by Application
10.3.1 Middle East & Africa Atrial Fibrillation Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Atrial Fibrillation Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Atrial Fibrillation Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Atrial Fibrillation Treatment Market Size by Country
10.4.1 Middle East & Africa Atrial Fibrillation Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Atrial Fibrillation Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Atrial Fibrillation Treatment Introduction
11.1.4 Johnson & Johnson Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.1.5 Johnson & Johnson Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Atrial Fibrillation Treatment Introduction
11.2.4 Abbott Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Atrial Fibrillation Treatment Introduction
11.3.4 Medtronic Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.3.5 Medtronic Recent Development
11.4 Boston Scientific
11.4.1 Boston Scientific Company Details
11.4.2 Boston Scientific Business Overview
11.4.3 Boston Scientific Atrial Fibrillation Treatment Introduction
11.4.4 Boston Scientific Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.4.5 Boston Scientific Recent Development
11.5 Siemens
11.5.1 Siemens Company Details
11.5.2 Siemens Business Overview
11.5.3 Siemens Atrial Fibrillation Treatment Introduction
11.5.4 Siemens Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.5.5 Siemens Recent Development
11.6 Biotronik
11.6.1 Biotronik Company Details
11.6.2 Biotronik Business Overview
11.6.3 Biotronik Atrial Fibrillation Treatment Introduction
11.6.4 Biotronik Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.6.5 Biotronik Recent Development
11.7 Koninklijke Philips
11.7.1 Koninklijke Philips Company Details
11.7.2 Koninklijke Philips Business Overview
11.7.3 Koninklijke Philips Atrial Fibrillation Treatment Introduction
11.7.4 Koninklijke Philips Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.7.5 Koninklijke Philips Recent Development
11.8 AtriCure
11.8.1 AtriCure Company Details
11.8.2 AtriCure Business Overview
11.8.3 AtriCure Atrial Fibrillation Treatment Introduction
11.8.4 AtriCure Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.8.5 AtriCure Recent Development
11.9 CardioFocus
11.9.1 CardioFocus Company Details
11.9.2 CardioFocus Business Overview
11.9.3 CardioFocus Atrial Fibrillation Treatment Introduction
11.9.4 CardioFocus Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.9.5 CardioFocus Recent Development
11.10 MicroPort Scientific
11.10.1 MicroPort Scientific Company Details
11.10.2 MicroPort Scientific Business Overview
11.10.3 MicroPort Scientific Atrial Fibrillation Treatment Introduction
11.10.4 MicroPort Scientific Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.10.5 MicroPort Scientific Recent Development
11.11 Sichuan Jinjiang Electronic Science and Technology
11.11.1 Sichuan Jinjiang Electronic Science and Technology Company Details
11.11.2 Sichuan Jinjiang Electronic Science and Technology Business Overview
11.11.3 Sichuan Jinjiang Electronic Science and Technology Atrial Fibrillation Treatment Introduction
11.11.4 Sichuan Jinjiang Electronic Science and Technology Revenue in Atrial Fibrillation Treatment Business (2016-2021)
11.11.5 Sichuan Jinjiang Electronic Science and Technology Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Atrial Fibrillation Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medications
Table 3. Key Players of Non-Surgical Procedures
Table 4. Key Players of Surgical Procedures
Table 5. Global Atrial Fibrillation Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Atrial Fibrillation Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Atrial Fibrillation Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Atrial Fibrillation Treatment Market Share by Regions (2016-2021)
Table 9. Global Atrial Fibrillation Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Atrial Fibrillation Treatment Market Share by Regions (2022-2027)
Table 11. Atrial Fibrillation Treatment Market Trends
Table 12. Atrial Fibrillation Treatment Market Drivers
Table 13. Atrial Fibrillation Treatment Market Challenges
Table 14. Atrial Fibrillation Treatment Market Restraints
Table 15. Global Atrial Fibrillation Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Atrial Fibrillation Treatment Market Share by Players (2016-2021)
Table 17. Global Top Atrial Fibrillation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrial Fibrillation Treatment as of 2020)
Table 18. Ranking of Global Top Atrial Fibrillation Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Atrial Fibrillation Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Atrial Fibrillation Treatment Product Solution and Service
Table 22. Date of Enter into Atrial Fibrillation Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Atrial Fibrillation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Atrial Fibrillation Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Atrial Fibrillation Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Atrial Fibrillation Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Atrial Fibrillation Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Atrial Fibrillation Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Atrial Fibrillation Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Atrial Fibrillation Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Atrial Fibrillation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Atrial Fibrillation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Atrial Fibrillation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Atrial Fibrillation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Atrial Fibrillation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Atrial Fibrillation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Atrial Fibrillation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Atrial Fibrillation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Atrial Fibrillation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Atrial Fibrillation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Atrial Fibrillation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Atrial Fibrillation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Atrial Fibrillation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Atrial Fibrillation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Atrial Fibrillation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Atrial Fibrillation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Atrial Fibrillation Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Atrial Fibrillation Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Atrial Fibrillation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Atrial Fibrillation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Atrial Fibrillation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Atrial Fibrillation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Atrial Fibrillation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Atrial Fibrillation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Atrial Fibrillation Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Atrial Fibrillation Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Atrial Fibrillation Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Atrial Fibrillation Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Atrial Fibrillation Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Atrial Fibrillation Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. Johnson & Johnson Company Details
Table 63. Johnson & Johnson Business Overview
Table 64. Johnson & Johnson Atrial Fibrillation Treatment Product
Table 65. Johnson & Johnson Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 66. Johnson & Johnson Recent Development
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Atrial Fibrillation Treatment Product
Table 70. Abbott Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Medtronic Company Details
Table 73. Medtronic Business Overview
Table 74. Medtronic Atrial Fibrillation Treatment Product
Table 75. Medtronic Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 76. Medtronic Recent Development
Table 77. Boston Scientific Company Details
Table 78. Boston Scientific Business Overview
Table 79. Boston Scientific Atrial Fibrillation Treatment Product
Table 80. Boston Scientific Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 81. Boston Scientific Recent Development
Table 82. Siemens Company Details
Table 83. Siemens Business Overview
Table 84. Siemens Atrial Fibrillation Treatment Product
Table 85. Siemens Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 86. Siemens Recent Development
Table 87. Biotronik Company Details
Table 88. Biotronik Business Overview
Table 89. Biotronik Atrial Fibrillation Treatment Product
Table 90. Biotronik Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 91. Biotronik Recent Development
Table 92. Koninklijke Philips Company Details
Table 93. Koninklijke Philips Business Overview
Table 94. Koninklijke Philips Atrial Fibrillation Treatment Product
Table 95. Koninklijke Philips Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 96. Koninklijke Philips Recent Development
Table 97. AtriCure Company Details
Table 98. AtriCure Business Overview
Table 99. AtriCure Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 100. AtriCure Recent Development
Table 101. CardioFocus Company Details
Table 102. CardioFocus Business Overview
Table 103. CardioFocus Atrial Fibrillation Treatment Product
Table 104. CardioFocus Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 105. CardioFocus Recent Development
Table 106. MicroPort Scientific Company Details
Table 107. MicroPort Scientific Business Overview
Table 108. MicroPort Scientific Atrial Fibrillation Treatment Product
Table 109. MicroPort Scientific Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 110. MicroPort Scientific Recent Development
Table 111. Sichuan Jinjiang Electronic Science and Technology Company Details
Table 112. Sichuan Jinjiang Electronic Science and Technology Business Overview
Table 113. Sichuan Jinjiang Electronic Science and Technology Atrial Fibrillation Treatment Product
Table 114. Sichuan Jinjiang Electronic Science and Technology Revenue in Atrial Fibrillation Treatment Business (2016-2021) & (US$ Million)
Table 115. Sichuan Jinjiang Electronic Science and Technology Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Atrial Fibrillation Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medications Features
Figure 3. Non-Surgical Procedures Features
Figure 4. Surgical Procedures Features
Figure 5. Global Atrial Fibrillation Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Atrial Fibrillation Treatment Report Years Considered
Figure 10. Global Atrial Fibrillation Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Atrial Fibrillation Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Atrial Fibrillation Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Atrial Fibrillation Treatment Market Share by Regions (2022-2027)
Figure 14. Global Atrial Fibrillation Treatment Market Share by Players in 2020
Figure 15. Global Top Atrial Fibrillation Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Atrial Fibrillation Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Atrial Fibrillation Treatment Revenue in 2020
Figure 17. Global Atrial Fibrillation Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Atrial Fibrillation Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Atrial Fibrillation Treatment Market Share by Type (2016-2027)
Figure 21. North America Atrial Fibrillation Treatment Market Share by Application (2016-2027)
Figure 22. North America Atrial Fibrillation Treatment Market Share by Country (2016-2027)
Figure 23. United States Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Atrial Fibrillation Treatment Market Share by Type (2016-2027)
Figure 27. Europe Atrial Fibrillation Treatment Market Share by Application (2016-2027)
Figure 28. Europe Atrial Fibrillation Treatment Market Share by Country (2016-2027)
Figure 29. Germany Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Atrial Fibrillation Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Atrial Fibrillation Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Atrial Fibrillation Treatment Market Share by Region (2016-2027)
Figure 39. China Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Atrial Fibrillation Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Atrial Fibrillation Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Atrial Fibrillation Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Atrial Fibrillation Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Atrial Fibrillation Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Atrial Fibrillation Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Atrial Fibrillation Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Johnson & Johnson Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 59. Abbott Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 60. Medtronic Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 61. Boston Scientific Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 62. Siemens Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 63. Biotronik Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 64. Koninklijke Philips Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 65. AtriCure Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 66. CardioFocus Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 67. MicroPort Scientific Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 68. Sichuan Jinjiang Electronic Science and Technology Revenue Growth Rate in Atrial Fibrillation Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed

Global Stroke Prevention in Atrial Fibrillation (SPAF) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z6207 2021年4月 90Pages
QYResearch社発行の本調査資料では、心房細動（SPAF）治療における脳卒中予防のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（経口用直接トロンビン阻害剤、経口用直接因子Xa阻害剤）、用途別市場規模（病院、診療所、外来手術センター）、主要...

世界の心房細動（AF）診断市場規模・現状・予測（2021年-2027年）

Global Atrial Fibrillation (AF) Diagnostics Market Size, Status and Forecast 2021-2027
QYR2104Z0497 2021年4月 99Pages
QYResearch社発行の本調査資料では、心房細動（AF）診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心電図（ECG）、心エコー図（エコー）、経食道心エコー検査（TEE）、胸部X線、血液検査、ストレス検査、電気的活動検査）、用途別市場...

世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年）

Global Acute Intermittent Porphyria Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0060 2021年4月 92Pages
QYResearch社発行の本調査資料では、急性間欠性ポルフィリン症（AIP）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（350mg、313mg）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界のアデノシンデアミナーゼ欠損症（ADA）治療市場規模・現状・予測（2021年-2027年）

Global Adenosine Deaminase Deficiency Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0096 2021年4月 96Pages
QYResearch社発行の本調査資料では、アデノシンデアミナーゼ欠損症（ADA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダーゲン、レブコビ）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、...

世界の神経精神障害＆治療市場規模・現状・予測（2021年-2027年）

Global Neuropsychiatric Disorders and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4097 2021年4月 97Pages
QYResearch社発行の本調査資料では、神経精神障害＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（薬物治療、ショック治療、その他）、用途別市場規模（病院、診療所、研究センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...

世界の神経性食欲不振症（AN）治療市場規模・現状・予測（2021年-2027年）

Global Anorexia Nervosa Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0355 2021年4月 94Pages
QYResearch社発行の本調査資料では、神経性食欲不振症（AN）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（心理療法、薬理療法、その他）、用途別市場規模（病院、クリニック、在宅医療、その他）、主要地域別市場規模（北米、アメリカ、ヨー...

世界の顕微鏡的多発血管炎（MPA）治療市場規模・現状・予測（2021年-2027年）

Global Microscopic Polyangiitis (MPA) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3776 2021年4月 98Pages
QYResearch社発行の本調査資料では、顕微鏡的多発血管炎（MPA）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アバコパン、免疫グロブリン、リツキシマブバイオシミラー、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別...

世界の髄膜炎診断・治療市場規模・現状・予測（2021年-2027年）

Global Meningitis Diagnosis and Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3698 2021年4月 95Pages
QYResearch社発行の本調査資料では、髄膜炎診断・治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ウイルス性髄膜炎、細菌性髄膜炎、その他）、用途別市場規模（病院・クリニック、診断センター）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界のHIV診断＆治療市場規模・現状・予測（2021年-2027年）

Global HIV Diagnosis & Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z2855 2021年4月 90Pages
QYResearch社発行の本調査資料では、HIV診断＆治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（ELISA検査、唾液検査、ウイルス量検査、ウエスタンブロット、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、ア...

世界の経口血糖降下薬（OAD）治療市場規模・現状・予測（2021年-2027年）

Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z4299 2021年4月 92Pages
QYResearch社発行の本調査資料では、経口血糖降下薬（OAD）治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（スルホニル尿素剤、ビグアニド、腸内α-グルコシダーゼ阻害剤、その他）、用途別市場規模（病院、診療所、糖尿病治療センター、その...

世界の心房細動（SPAF）治療における脳卒中予防市場規模・現状・予測（2021年-2027年） Atrial fibrillation (AF) now a days has become a common and serious condition affecting almost 1-2% of the total population of age group 65 years and above. Increase in the aging population leads to increase in the prevalence further leads to increase rick of premature death. Market Analysis and Ins…
世界の心房細動（AF）診断市場規模・現状・予測（2021年-2027年） Atrial fibrillation (AF) is a type of cardiac arrhythmia which is caused by irregular electrical activities in the atria. It may occur with no symptoms but most common ones associated with it are fainting, palpitations, congestive failure of the heart or chest pain. Factors such as aging of populati…
世界の肥満外科手術市場規模・現状・予測（2021年-2027年） Obesity is a medical condition which occurs due to excessive fat accumulation leading to adverse effect on health. Few of the prime reason for obesity are excessive food intake, less physical exercise and genetic susceptibility. According to the World Health Organization (WHO), the body mass index (…
世界の心耳用オクルーダー市場 2021：企業別、地域別、種類・用途別 The Atrial Appendage Occluder market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regul…
世界の非外科的美容処置市場規模・現状・予測（2021年-2027年） Aging is considered a serious aesthetic issue. Signs of aging include wrinkles around eyes or lips, age spots, and sagging skin. There used to be few options for turning back the clock without undergoing surgery. However, currently, one can soften the effects of time on the face with several non-sur…